ATLASPhio Pharmaceuticals (PHIO) earnings date: Nov 12, 2026
Phio Pharmaceuticals (PHIO) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026. Analysts expect EPS of -$0.36.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PHIO
| Last price | $0.89 (+3.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.4% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Phio Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Phio Pharmaceuticals reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Phio Pharmaceuticals. You can switch it off at any time.
Alert me before PHIO reportsFree to start. Creating an account takes under a minute.
Notify me when Phio Pharmaceuticals reports
Track PHIO free Add Phio Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
PHIO earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.36 |
| Last report | Aug 6, 2026 · In line |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | +2.4% |
| Average move around a report | ±4.9% (last 4) |
| Sector | Healthcare · Biotechnology |
Phio Pharmaceuticals earnings history: last 4 reports
Phio Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.36 against an estimate of -$0.36 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.36 | -$0.36 | 0.0% | In line | -2.8% |
| May 7, 2026 | -$0.23 | -$0.34 | -47.8% | Miss | -7.0% |
| Mar 5, 2026 | -$0.47 | -$0.15 | +68.1% | Beat | +0.9% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | -8.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PHIO
See the fair value, the probability range and the earnings history of Phio Pharmaceuticals on its ATLAS page.
Phio Pharmaceuticals (PHIO) stock analysisPlans from €3.99 a month.
Phio Pharmaceuticals earnings: frequently asked questions
When does Phio Pharmaceuticals (PHIO) report earnings?
Phio Pharmaceuticals is scheduled to report on Thursday, November 12, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PHIO?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.36 per share (USD). Estimates can change before the report.
How often does PHIO beat earnings estimates?
Of its last 4 reports with a recorded result, Phio Pharmaceuticals beat the EPS estimate 1 times; the average surprise was +2.4%. Past results do not predict the next one.
How much does PHIO move around earnings?
Over its last 4 reports the stock moved an average of 4.9% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Phio Pharmaceuticals beat earnings estimates last quarter?
Phio Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.36 against an estimate of -$0.36 (0.0% surprise), in line with the estimate.
How much does PHIO usually move in a day?
On a normal trading day the ATLAS model puts PHIO’s one-day range at about ±3.4%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer